AB Science S.A. (0Q77)
LSE
Closed
Oct 9, 2026
Day's Range
0.521052 wk Range
0.5080Overview - 0Q77 - AB Science S.A.
Key Statistics
Valuation
Enterprise Value
53.10M
P/E (Trailing)
‪-52.10‬
EV / EBITDA
‪-8.31‬
Profitability
Profit Margin
‪0.00%‬
Operating Margin
‪-2,090.96%‬
Return on Assets
‪-22.40%‬
Return on Equity
‪-6.76%‬
Ownership
Shares Outstanding
41.06M
Float
17.20M
Held by Insiders
‪47.70%‬
Held by Institutions
‪0.0030%‬
Price stats
50-Day Avg
‪3.15‬
200-Day Avg
‪3.21‬
Market Cap - 0Q77 - AB Science S.A.
Peers - 0Q77 - AB Science S.A.
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on LSE.
- 0Q77LSEAB Science S.A.21.39MMarket Cap-147.60%52-week change-52.10P/E (Trailing)‪0.00%‬Profit Margin
- HLNLSEHaleon plc2.88TMarket Cap-1.07%52-week change18.76P/E (Trailing)‪14.55%‬Profit Margin
- 0QFPLSEGedeon Richter Plc.1.74TMarket Cap+0.00%52-week change7.34P/E (Trailing)‪19.72%‬Profit Margin
- ROSELSERosebank Industries plc306.41BMarket Cap-12.90%52-week change—P/E (Trailing)‪-4.92%‬Profit Margin
- HCMLSEHUTCHMED (China) Limited187.71BMarket Cap-9.26%52-week change108.00P/E (Trailing)‪3.25%‬Profit Margin
- 0MTDLSESwedish Orphan Biovitrum AB154.73BMarket Cap+30.35%52-week change44.11P/E (Trailing)‪15.54%‬Profit Margin
- 0O14LSEMerck KGaA62.53BMarket Cap+20.64%52-week change19.12P/E (Trailing)‪13.95%‬Profit Margin
Profile Summary - 0Q77 - AB Science S.A.
About
AB Science S.A. is a clinical-stage pharmaceutical company headquartered in Paris, France, founded in 2001. It specializes in the research, design, development, and marketing of innovative drugs targeting diseases with high unmet medical needs, particularly in oncology, inflammatory diseases, and neurological…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
